MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Regression of left ventricular hypertrophy during treatment with antihypertensive agents.
Hypertension: Benefit of pharmacists prescribing antihypertensive medication.
Risk-benefit aspects of antihypertensive drugs.
Antihypertensive agents and arterial stiffness.
Factors influencing the choice of antihypertensive agents.
Hyperkalaemia and overdose of antihypertensive agents.
Hyperkalaemia and overdose of antihypertensive agents.
Using benefit-based tailored treatment to improve the use of antihypertensive medications.
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
Quinazolinylformamidines and quinazolinediylbisformamidines as antihypertensive agents.
cardiovascular agents.
The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted).
Feasibility of regression of hypertension using contemporary antihypertensive agents.
Evaluation of antihypertensive agents in the stress-induced hypertensive rat.
Sexual function of women taking antihypertensive agents: a comparative study.
Dangerous antihypertensive treatment.
Dangerous antihypertensive treatment.
Withdrawing antihypertensive treatment.
Withdrawing antihypertensive treatment.
Dangerous antihypertensive treatment.
Dangerous antihypertensive treatment.
Dangerous antihypertensive treatment.
New antihypertensive agents: benefit of treatment.
Large-scale end-point trials have demonstrated that antihypertensive treatment reverses the risk of stroke attributable to high blood pressure and pro...
345KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Regression of left ventricular hypertrophy during treatment with antihypertensive agents.
Hypertension: Benefit of pharmacists prescribing antihypertensive medication.
Risk-benefit aspects of antihypertensive drugs.
Antihypertensive agents and arterial stiffness.
Factors influencing the choice of antihypertensive agents.
Hyperkalaemia and overdose of antihypertensive agents.
Hyperkalaemia and overdose of antihypertensive agents.
Using benefit-based tailored treatment to improve the use of antihypertensive medications.
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
Quinazolinylformamidines and quinazolinediylbisformamidines as antihypertensive agents.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
